CA2312505A1 - Compositions de resveratrol pour usage topique lors du traitement de maladies et d'infections buccales - Google Patents

Compositions de resveratrol pour usage topique lors du traitement de maladies et d'infections buccales Download PDF

Info

Publication number
CA2312505A1
CA2312505A1 CA002312505A CA2312505A CA2312505A1 CA 2312505 A1 CA2312505 A1 CA 2312505A1 CA 002312505 A CA002312505 A CA 002312505A CA 2312505 A CA2312505 A CA 2312505A CA 2312505 A1 CA2312505 A1 CA 2312505A1
Authority
CA
Canada
Prior art keywords
composition
resveratrol
disease comprises
tcdd
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002312505A
Other languages
English (en)
Inventor
Howard Tenenbaum
Robert Casper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
1333366 Ontario Inc
Original Assignee
1333366 Ontario Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 1333366 Ontario Inc filed Critical 1333366 Ontario Inc
Priority to CA002312505A priority Critical patent/CA2312505A1/fr
Publication of CA2312505A1 publication Critical patent/CA2312505A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002312505A 2000-06-27 2000-06-27 Compositions de resveratrol pour usage topique lors du traitement de maladies et d'infections buccales Abandoned CA2312505A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002312505A CA2312505A1 (fr) 2000-06-27 2000-06-27 Compositions de resveratrol pour usage topique lors du traitement de maladies et d'infections buccales

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002312505A CA2312505A1 (fr) 2000-06-27 2000-06-27 Compositions de resveratrol pour usage topique lors du traitement de maladies et d'infections buccales

Publications (1)

Publication Number Publication Date
CA2312505A1 true CA2312505A1 (fr) 2001-12-27

Family

ID=4166580

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002312505A Abandoned CA2312505A1 (fr) 2000-06-27 2000-06-27 Compositions de resveratrol pour usage topique lors du traitement de maladies et d'infections buccales

Country Status (1)

Country Link
CA (1) CA2312505A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1450819A1 (fr) * 2001-11-02 2004-09-01 The Regents of the University of California Methodes et compositions destinees a la prevention et au traitement d'une maladie inflammatoire, d'une maladie auto-immune et du rejet de greffe
WO2006127987A2 (fr) * 2005-05-25 2006-11-30 Sirtris Pharmaceuticals, Inc. Traitement de troubles oculaires par modulateurs de sirtuine
WO2011084781A3 (fr) * 2009-12-21 2011-11-10 Colgate-Palmolive Company Compositions et procédés de soin oral
US11103465B2 (en) 2017-11-22 2021-08-31 Ted's Brain Science, Inc. Trans-resveratrol topical medication for the treatment of pain and method of manufacture thereof

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1450819A1 (fr) * 2001-11-02 2004-09-01 The Regents of the University of California Methodes et compositions destinees a la prevention et au traitement d'une maladie inflammatoire, d'une maladie auto-immune et du rejet de greffe
EP1450819A4 (fr) * 2001-11-02 2008-01-23 Univ California Methodes et compositions destinees a la prevention et au traitement d'une maladie inflammatoire, d'une maladie auto-immune et du rejet de greffe
EP2289499A3 (fr) * 2001-11-02 2012-05-16 The Regents of the University of California Procédés et compositions pour la prévention et le traitement de maladie inflammatoire, maladie auto-immune, et rejet d'implant
WO2006127987A2 (fr) * 2005-05-25 2006-11-30 Sirtris Pharmaceuticals, Inc. Traitement de troubles oculaires par modulateurs de sirtuine
WO2006127987A3 (fr) * 2005-05-25 2008-04-17 Sirtris Pharmaceuticals Inc Traitement de troubles oculaires par modulateurs de sirtuine
WO2011084781A3 (fr) * 2009-12-21 2011-11-10 Colgate-Palmolive Company Compositions et procédés de soin oral
US8883179B2 (en) 2009-12-21 2014-11-11 Colgate-Palmolive Company Oral care compositions and methods
US9320696B2 (en) 2009-12-21 2016-04-26 Colgate-Palmolive Company Oral care compositions and methods
US11103465B2 (en) 2017-11-22 2021-08-31 Ted's Brain Science, Inc. Trans-resveratrol topical medication for the treatment of pain and method of manufacture thereof

Similar Documents

Publication Publication Date Title
US6716883B1 (en) Composition useful to treat periodontal disease
TWI396557B (zh) 含有未氧化山茶花（ｃａｍｅｌｌｉａ）萃取物之口腔保健組成物
JP5684454B2 (ja) 口腔ケア用の治療及び予防組成物
US20060264497A1 (en) Diindolylmethane-based compositions and methods of use thereof for promoting oral mucosal and bone health
BRPI0412752B1 (pt) Composição de filme de dissolução oral
US20070110683A1 (en) Oral care formulation
Lif Holgerson et al. Xylitol concentration in saliva and dental plaque after use of various xylitol-containing products
EP1140050B1 (fr) Composition utile pour traiter la parodontopathie
RU2414210C1 (ru) Средство для удаления табачных смол и композиции на его основе
WO2006109344A2 (fr) Composition pour le traitement de pathologie parodontale
US7087219B2 (en) Toothpaste containing anticancer agents
WO2000056344A1 (fr) Salive artificielle
KR20060015588A (ko) 구강 케어 방법 및 제품
JP6486601B2 (ja) オーラルケア組成物
KR20160124007A (ko) 염증성 질환 또는 통증 예방 또는 치료용 조성물
CA2312505A1 (fr) Compositions de resveratrol pour usage topique lors du traitement de maladies et d'infections buccales
US20110150974A1 (en) Agent For Oral Mucosal Administration
CN103957870B (zh) 包含正丁基厚朴酚和异丁基厚朴酚的口腔护理组合物
CN108403544A (zh) 一种儿童口腔护理组合物及其制备方法
KR20110001472A (ko) 센틸라아시아티카 추출물 및 구강조직수렴제를 포함하는 구강 조성물
JP2000273051A (ja) 苦みがマスキングされた液状製剤
KR0179523B1 (ko) 치은염 치료용 유향과 창출 추출물 함유 치약조성물
WO2016195089A1 (fr) Promoteur de la salivation, inhibiteur de xérostomie, agent d'hydratation de la cavité buccale, et compositions
TW201141536A (en) Oral care compositions and methods
US20040028623A1 (en) Formulations for the removal of dental plaque, tartar and dental stains

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead